A prospective randomized controlled study of Mycobacterium Indicus Pranii vaccine, Measles Mumps Rubella vaccine and Vitamin D3 in extragenital cutaneous warts
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15564 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Utkrist Lahoria und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, All India Institute of Medical Sciences, Jodhpur, India. Hauptthemen laut MEDLINE: Warts, Papilloma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Design
Interventional, prospective, four arm randomized control.
Setting
Outpatient department, Department of Dermatology, Venereology and Leprology, AIIMS Jodhpur (Rajasthan), India.
Participants
Two hundred patients.
Methods
The intervention administered in the groups were normal saline (A), vitamin D 3 (B), MIP (C), and MMR (D). The injections were given into the largest wart at 2‐weekly intervals until complete clearance or for a maximum of seven sittings. Post‐treatment clearance of the injected wart and the distant wart was compared on the basis of change in wart number, percentage clearance, and mean time to complete clearance. Side effects were recorded.
Results
A total of 197 patients were recruited. The mean percentage improvement in the injected and non‐injected warts was 68.4% and 66.8%, respectively. Intention to treat analysis (ITT) showed that complete clearance of lesions in injected wart occurred in placebo, vit D 3 , MMR, and MIP arms in 64%, 66%, 58%, and 55% patients, respectively ( p > 0.05), while in the non‐injected warts in 62%, 64%, 52%, and 53%, respectively ( p > 0.05). The mean time to achieve complete clearance of wart was fastest in MIP at 7.1 weeks followed by MMR at 7.2 weeks, VIT D 3 at 7.4 weeks and in placebo group 7.8 weeks ( p > 0.05). Side effects noted were fever, pain, erythema, and swelling which was highest in VIT D 3 group ( p < 0.05).
Conclusion
The efficacy of immunotherapies was comparable to placebo with minimal side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, All India Institute of Medical Sciences, Jodhpur, India.
- Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India.
ORCID-Profile: Utkrist Lahoria, Saurabh Singh
Zitieren
APA
Lahoria, U., Singh, S., Bhardwaj, A., Budania, A., Chhajed, N., Rajagopal, S. V., & Singh, S. (2023). A prospective randomized controlled study of Mycobacterium Indicus Pranii vaccine, Measles Mumps Rubella vaccine and Vitamin D3 in extragenital cutaneous warts. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15564
Vancouver
Lahoria U, Singh S, Bhardwaj A, Budania A, Chhajed N, Rajagopal SV, et al. A prospective randomized controlled study of Mycobacterium Indicus Pranii vaccine, Measles Mumps Rubella vaccine and Vitamin D3 in extragenital cutaneous warts. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15564
BibTeX
@article{Lahoria2023,
author = {Lahoria, Utkrist and Singh, Saurabh and Bhardwaj, Abhishek and Budania, Anil and Chhajed, Neelam and Rajagopal, Srinivasan Varun and Singh, Surjit},
title = {A prospective randomized controlled study of Mycobacterium Indicus Pranii vaccine, Measles Mumps Rubella vaccine and Vitamin D3 in extragenital cutaneous warts},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15564}
}
EUVIMED